Roger Rahmani

5.9k total citations
137 papers, 4.9k citations indexed

About

Roger Rahmani is a scholar working on Pharmacology, Molecular Biology and Oncology. According to data from OpenAlex, Roger Rahmani has authored 137 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Pharmacology, 44 papers in Molecular Biology and 35 papers in Oncology. Recurrent topics in Roger Rahmani's work include Pharmacogenetics and Drug Metabolism (44 papers), Carcinogens and Genotoxicity Assessment (16 papers) and Drug Transport and Resistance Mechanisms (16 papers). Roger Rahmani is often cited by papers focused on Pharmacogenetics and Drug Metabolism (44 papers), Carcinogens and Genotoxicity Assessment (16 papers) and Drug Transport and Resistance Mechanisms (16 papers). Roger Rahmani collaborates with scholars based in France, United States and Morocco. Roger Rahmani's co-authors include Georges de Sousa, G. Lemaire, M. Placidi, Ludovic Peyre, Xiaojian Zhou, C. Delescluse, Christine Risso-de Faverney, Nathalie Zucchini-Pascal, Patrick Balaguer and Pascale Mauvais and has published in prestigious journals such as Nature Communications, Analytical Biochemistry and Chemosphere.

In The Last Decade

Roger Rahmani

136 papers receiving 4.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roger Rahmani France 43 1.3k 1.3k 1.2k 1.1k 514 137 4.9k
Jeroen Buters Germany 39 1.4k 1.0× 1.3k 1.0× 1.6k 1.4× 1.2k 1.0× 522 1.0× 131 5.6k
James Winfred Bridges United Kingdom 39 1.5k 1.1× 859 0.7× 1.4k 1.2× 648 0.6× 621 1.2× 191 4.8k
Bas J. Blaauboer Netherlands 37 1.3k 1.0× 1.4k 1.1× 885 0.7× 397 0.4× 661 1.3× 134 4.6k
Douglas C. Wolf United States 42 1.4k 1.1× 1.6k 1.2× 516 0.4× 377 0.3× 1.1k 2.1× 209 5.8k
Olivier Fardel France 52 2.4k 1.8× 1.3k 1.0× 1.2k 1.0× 3.4k 3.0× 635 1.2× 214 8.3k
Georges de Sousa France 31 630 0.5× 518 0.4× 656 0.6× 481 0.4× 287 0.6× 76 2.4k
Zdeněk Dvořák Czechia 42 2.0k 1.5× 739 0.6× 1.6k 1.4× 1.7k 1.5× 441 0.9× 256 6.3k
M I Luster United States 38 762 0.6× 1.9k 1.5× 549 0.5× 318 0.3× 951 1.9× 87 5.8k
Colin J. Henderson United Kingdom 45 4.6k 3.4× 559 0.4× 2.4k 2.0× 1.7k 1.5× 750 1.5× 166 8.6k
Hideki Wanibuchi Japan 40 2.7k 2.0× 1.0k 0.8× 337 0.3× 946 0.8× 1.3k 2.5× 305 6.2k

Countries citing papers authored by Roger Rahmani

Since Specialization
Citations

This map shows the geographic impact of Roger Rahmani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger Rahmani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger Rahmani more than expected).

Fields of papers citing papers by Roger Rahmani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roger Rahmani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger Rahmani. The network helps show where Roger Rahmani may publish in the future.

Co-authorship network of co-authors of Roger Rahmani

This figure shows the co-authorship network connecting the top 25 collaborators of Roger Rahmani. A scholar is included among the top collaborators of Roger Rahmani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roger Rahmani. Roger Rahmani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alarcan, Jimmy, Georges de Sousa, Efrosini S. Katsanou, et al.. (2021). Investigating the in vitro steatotic mixture effects of similarly and dissimilarly acting test compounds using an adverse outcome pathway-based approach. Archives of Toxicology. 96(1). 211–229. 8 indexed citations
2.
Kadar, Ali, Georges de Sousa, Ludovic Peyre, et al.. (2017). Evidence of in vitro metabolic interaction effects of a chlorfenvinphos, ethion and linuron mixture on human hepatic detoxification rates. Chemosphere. 181. 666–674. 8 indexed citations
3.
Kadar, Ali, Ludovic Peyre, Gabriela Freitas Pereira de Souza, et al.. (2017). An accurate and robust LC-MS/MS method for the quantification of chlorfenvinphos, ethion and linuron in liver samples. Chemosphere. 184. 20–26. 8 indexed citations
4.
Braud, Laura, Sylvain Battault, Grégory Meyer, et al.. (2016). 0149 : Antioxidant molecules of tea (Camellia sinensis) decrease hepatic lipogenesis and steatosis in a high fat-sucrose diet NAFLD rat model. Archives of Cardiovascular Diseases Supplements. 8(3). 213–213. 3 indexed citations
5.
Beaudouin, Rémy, et al.. (2015). BK/TD models for analyzing in vitro impedance data on cytotoxicity. Toxicology Letters. 235(2). 96–106. 8 indexed citations
6.
7.
8.
Sousa, Georges de, Ahmad Nawaz, Jean‐Pierre Cravedi, & Roger Rahmani. (2014). A Concentration Addition Model to Assess Activation of the Pregnane X Receptor (PXR) by Pesticide Mixtures Found in the French Diet. Toxicological Sciences. 141(1). 234–243. 10 indexed citations
9.
Lemaire, G., C. Delescluse, M. Pralavorio, et al.. (2004). The role of protein tyrosine kinases in CYP1A1 induction by omeprazole and thiabendazole in rat hepatocytes. Life Sciences. 74(18). 2265–2278. 58 indexed citations
10.
Lemaire, G., Patrick Balaguer, Serge Michel, & Roger Rahmani. (2004). Activation of retinoic acid receptor-dependent transcription by organochlorine pesticides. Toxicology and Applied Pharmacology. 202(1). 38–49. 56 indexed citations
11.
Bailly‐Maitre, Béatrice, et al.. (2002). True. Cell Death and Differentiation. 9(9). 945–955. 4 indexed citations
12.
Bailly‐Maitre, Béatrice, et al.. (2002). Spontaneous apoptosis in primary cultures of human and rat hepatocytes: molecular mechanisms and regulation by dexamethasone. Cell Death and Differentiation. 9(9). 945–955. 53 indexed citations
13.
Bailly‐Maitre, Béatrice, Georges de Sousa, Kim E. Boulukos, Jean Gugenheim, & Roger Rahmani. (2001). Dexamethasone inhibits spontaneous apoptosis in primary cultures of human and rat hepatocytes via Bcl-2 and Bcl-xL induction. Cell Death and Differentiation. 8(3). 279–288. 60 indexed citations
14.
Sousa, Georges de, M. Placidi, Roger Rahmani, et al.. (1999). A multi-laboratory evaluation of cryopreserved monkey hepatocyte functions for use in pharmaco–toxicology. Chemico-Biological Interactions. 121(1). 77–97. 15 indexed citations
15.
Bride, J.M., A. Cuany, Marcel Amichot, et al.. (1997). Cytochrome P-450 Field Insecticide Tolerance and Development of Laboratory Resistance in Grape Vine Populations of Drosophila melanogaster(Diptera: Drosophilidae). Journal of Economic Entomology. 90(6). 1514–1520. 9 indexed citations
16.
Sousa, Georges de, et al.. (1995). Relationships betweenin vitro andin vivo biotransformation of drugs in humans and animals: pharmaco-toxicological consequences. Cell Biology and Toxicology. 11(3-4). 147–153. 15 indexed citations
17.
Zhou, Xiaojian, et al.. (1994). Relative bioavailability of two oral formulations of navelbine in cancer patients. Biopharmaceutics & Drug Disposition. 15(7). 577–586. 13 indexed citations
18.
Placidi, M., et al.. (1993). Identification of the human and animal hepatic cytochromes P450 involved in clonazepam metabolism. Fundamental and Clinical Pharmacology. 7(2). 69–75. 45 indexed citations
19.
Dou, Mengjia, Georges de Sousa, Bruno Lacarelle, et al.. (1992). Thawed human hepatocytes in primary culture. Cryobiology. 29(4). 454–469. 69 indexed citations
20.
Zhou, Xiaolei, et al.. (1991). Pharmacokinetics of navelbine after oral administration in cancer patients. Cancer Chemotherapy and Pharmacology. 29(1). 66–70. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jeroen Buters Breakdown of academic impact, for papers by James Winfred Bridges Breakdown of academic impact, for papers by Bas J. Blaauboer Breakdown of academic impact, for papers by Douglas C. Wolf Breakdown of academic impact, for papers by Olivier Fardel Breakdown of academic impact, for papers by Georges de Sousa Breakdown of academic impact, for papers by Zdeněk Dvořák Breakdown of academic impact, for papers by M I Luster Breakdown of academic impact, for papers by Colin J. Henderson Breakdown of academic impact, for papers by Hideki Wanibuchi
Rankless by CCL
2026